Image 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Table 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Table 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 8_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 6_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 7_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Image 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Table 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Table 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…The right superior parietal gyrus may be implicated in impaired renal function during the progression of hypertension. …”

Table1_Trp-574-Leu and the novel Pro-197-His/Leu mutations contribute to penoxsulam resistance in Echinochloa crus-galli (L.) P. Beauv..docx by Penglei Sun (18343673)

“…Molecular docking studies revealed that Trp-574-Leu mutation primarily reduced the enzyme’s ability to bind to the triazole-pyrimidine ring of penoxsulam due to decreased π–π stacking interactions, while Pro-197-His/Leu mutations impaired binding to the benzene ring by altering hydrogen bonds and hydrophobic interactions. …”

<i>Irresistible</i>^<i>p173</i> is an allele of the Cadherin-encoding gene <i>cdh16.</i> by Susannah S. Schloss (21238775)

“…<b>(D)</b> <i>cdh16</i>^<i>co79</i> mutants (<i>n</i> = 39) have significantly impaired habituation (****<i>p</i> < 0.0001, Mann–Whitney test) compared to siblings (<i>n</i> = 32). …”